Independent register of U.S. FDA drug recalls · updated Oct 14, 2026
RxRecalls Get alerts

Class II drug recalls - moderate risk

Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.

14,543 recalls, newest first.

Class II · Moderate risk

Fayosim (levonorgestrel and ethinyl estradiol)

Failed Impurities/Degradation Specifications: Out-of-specification results observed in related substance test (Any Other Individual Impurity and Total impurities) in Ethinyl Estradiol Tablets USP 0.01mg at 12 month long term stability study.

Terminated Impurity / degradation Lupin Pharmaceuticals Inc. NDC 68180-860-11 D-1057-2019
Class II · Moderate risk

Gavilyte-N

Labeling Not Elsewhere Classified; orange and cherry flavor packets incorrect list "natural lemon flavor" as an ingredient

Terminated Labeling / mix-up Lupin Somerset NDC 43386-050-19 D-1113-2019
Class II · Moderate risk

Losartan 50mg Tablet

CGMP Deviations; Detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) - N-Methylnitrosobutyric acid (NMBA).

Terminated Nitrosamine impurity RemedyRepack Inc. D-1081-2019
Class II · Moderate risk

Red Eye

Lack of Assurance of Sterility: Product is not terminally sterialized and not tested per USP 71.

Terminated Sterility / contamination MSM Nutraceuticals, LLC D-1128-2019

Recalls by year